INSMED INC Payments of Debt Issuance Costs
INSMED INC (INSM) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-02-19
- INSMED INC payments of debt issuance costs for the quarter ending 2024-12-31 was $3.74M.
- INSMED INC payments of debt issuance costs for the quarter ending 2024-09-30 was $0.00.
- INSMED INC payments of debt issuance costs for the quarter ending 2024-06-30 was $0.00.
- INSMED INC payments of debt issuance costs for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC payments of debt issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- INSMED INC payments of debt issuance costs for fiscal 2024 was $3.74M, a 206.81% increase from fiscal 2023.
- INSMED INC payments of debt issuance costs for fiscal 2023 was $1.22M, a 93.15% decline from fiscal 2022.
- INSMED INC payments of debt issuance costs for fiscal 2022 was $17.78M, a 13.14% increase from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-19 | |||
| 2024-12-31 | $3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.74M derived: sum of 2 quarters · filed 2026-02-19 | $3.74M derived: sum of 3 quarters · filed 2026-02-19 | $3.74M 10-K · filed 2026-02-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $1.22M 10-K · filed 2026-02-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $1.22M 10-Q · filed 2024-10-31 | $19.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.22M 10-Q · filed 2024-08-08 | $19.00M derived: sum of 3 quarters · filed 2025-02-20 | $19.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.22M 10-Q · filed 2024-05-09 | $19.00M derived: sum of 2 quarters · filed 2025-02-20 | $19.00M derived: sum of 3 quarters · filed 2025-02-20 | $19.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $17.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $17.78M derived: sum of 2 quarters · filed 2025-02-20 | $17.78M derived: sum of 3 quarters · filed 2025-02-20 | $17.78M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | $16.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $16.00K derived: sum of 3 quarters · filed 2024-02-22 | -$295.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $16.00K derived: sum of 2 quarters · filed 2024-02-22 | -$295.00K derived: sum of 3 quarters · filed 2024-02-22 | |
| 2021-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$295.00K derived: sum of 2 quarters · filed 2024-02-22 | $15.72M 10-K · filed 2024-02-22 | |
| 2021-09-30 | -$311.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $15.70M 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | $16.01M 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $0.00 derived: sum of 2 quarters · filed 2022-02-17 | $0.00 derived: sum of 3 quarters · filed 2022-02-17 | $0.00 10-K · filed 2022-02-17 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | $2.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $2.00K derived: sum of 3 quarters · filed 2021-02-25 | $2.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $2.00K derived: sum of 2 quarters · filed 2021-02-25 | $2.00K derived: sum of 3 quarters · filed 2021-02-25 | $96.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.00K derived: sum of 2 quarters · filed 2021-02-25 | $96.00K derived: sum of 3 quarters · filed 2021-02-25 | $14.24M 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $94.00K derived: sum of 2 quarters · filed 2019-10-30 | $14.23M 10-Q · filed 2019-10-30 | $14.23M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $14.23M 10-Q · filed 2019-08-01 | $14.23M derived: sum of 3 quarters · filed 2020-02-25 | $14.23M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $14.14M 10-Q · filed 2019-05-07 | $14.14M derived: sum of 2 quarters · filed 2020-02-25 | $14.14M derived: sum of 3 quarters · filed 2020-02-25 | $14.14M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 | $103.00K derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | $103.00K derived: sum of 3 quarters · filed 2019-02-22 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | $103.00K derived: sum of 2 quarters · filed 2019-02-22 | ||
| 2016-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $411.00K 10-K · filed 2019-02-22 | ||
| 2016-09-30 | $308.00K 10-Q · filed 2017-11-02 | |||
| 2015-12-31 | $250.00K 10-K · filed 2018-02-23 | |||
| 2014-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $150.00K derived: sum of 2 quarters · filed 2017-02-23 | $250.00K 10-K · filed 2017-02-23 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $100.00K 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $100.00K 10-Q · filed 2015-08-06 | |||
| 2013-12-31 | $100.00K 10-K · filed 2016-02-25 | |||
| 2012-12-31 | $328.00K 10-K · filed 2015-02-27 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |